Morning-after Bolus Is Over The Adverse 2
Plan B has been accessible by decree to women of any age back 1999. Its maker, Barr Pharmaceuticals, has continued approved FDA approval to bazaar Plan B available over the counter.
In April 2003, Barr activated to bazaar Plan B an over-the-counter drug. In December 2003, an FDA advising board met to altercate Barr's application.
The board backed Barr's application. But the FDA absitively it bare more information about how Plan B could be cautiously acclimated by adolescents without supervision by a accountant practitioner.
In March 2004, Barr submitted addition application, this time attached Plan B's over-the-counter sales to women at atomic 16 years old.
In May 2004, the FDA beneath to complete its analysis of that application, calling Barr's angle "preliminary and incomplete."
Barr after submitted added advice in abutment of its application. In August 2005, the FDA afresh delayed a decision.
Lester M. Crawford, DVM, was FDA abettor at the time. He issued a statement on Aug. 26, 2005 citation "unresolved authoritative and policy issues" as the acumen for the delay.
In his statement, Crawford acclaimed that the FDA had assured "the available accurate abstracts are acceptable to abutment the safe use of Plan B as an over-the-counter product, but alone for women who are 17 years of age or older."
Susan Wood, abettor FDA abettor for women's bloom and administrator of the Office of Women's Health, accommodated in August 2005 in beef over the FDA's delays on Plan B.
Similiars
- Morning-after Bolus Is Over The Adverse- Fda Animate Backs Morning-after Bolus 2